Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | General Mills Inc | 33 |
| 2 | Ascendis Pharma AS | 27 |
| 3 | DSM Firmenich AG | 9 |
| 4 | Lineage Cell Therapeutics Inc | 9 |
| 5 | Boston Scientific Corp | 7 |
| 6 | Sanofi SA | 6 |
| 7 | Sinochem Holdings Corp Ltd | 5 |
| 8 | International Flavors and Fragrances Inc | 4 |
| 9 | Avenir Wellness Solutions Inc | 3 |
| 10 | Wockhardt Ltd | 3 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61K | Medicinal preparations | 151 |
| 2 | A61P | Therapeutic activity (drug indications) | 95 |
| 3 | A23L | Foods and beverages (general) | 47 |
| 4 | A23P | 35 | |
| 5 | Y02A | Climate change adaptation | 30 |
| 6 | A61Q | Cosmetics, personal care | 29 |
| 7 | A61M | Devices for introducing media into the body | 25 |
| 8 | B01J | Chemical/physical processes (e.g. catalysts) | 23 |
| 9 | A21D | 19 | |
| 10 | A23C | 19 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionRepresentative patents
The filings that best characterise the patent activity around this compound, most-referenced first.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| Embedding and encapsulation of controlled release particles | 2001 | General Mills Inc | 346 |
| BIODEGRADABLE POLYETHYLENE GLYCOL BASED WATER-INSOLUBLE HYDROGELS | 2011 | Ascendis Pharma AS | 176 |
| COMBINATORIAL ANALYSIS AND REPAIR | 2010 | Agilent Technologies Inc | 143 |
| Encapsulation of components into edible products | 2004 | General Mills Inc | 172 |
| Encapsulation of sensitive components into a matrix to obtain discrete shelf-stable particles | 2002 | General Mills Inc | 165 |
How research activity has moved
Papers published per year for this compound, over the last decade of indexed records.
| Year | Papers |
|---|---|
| 2016 | 1 |
| 2019 | 1 |
| 2020 | 1 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Ebbe Søndergaard | Rigshospitalet | 6 |
| 2 | Henrik Dam | Rigshospitalet | 5 |
| 3 | H Dyggve | Rigshospitalet | 4 |
| 4 | D.H. Marrian | University of Cambridge | 3 |
| 5 | H. K. Hanel | 3 |
| 6 | Sigismund Neukomm | 3 | |
| 7 | E Quagliariello | 3 | |
| 8 | G. Hjort | 3 | |
| 9 | L Peguiron | 2 | |
| 10 | P. R. Purser | 2 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Menadione-induced Reactive Oxygen Species Generation via Redox Cycling Promotes Apoptosis of Murine Pancreatic Acinar Cells | 2006 | 384 | Pancreatitis Pathology and Treatment |
| Quinone Oxidoreductases and Vitamin K Metabolism | 2008 | 93 | Alcoholism and Thiamine Deficiency |
| The Effect of Large Doses of Synkavit in the Newborn | 1956 | 75 | Urological Disorders and Treatments |
| Comparison of the Action of Vitamin K1, Menadione and Synkavit administered Intravenously to Vitamin K Deficient Chicks. | 1953 | 43 | Vitamin K Research Studies |
| Phase I trial of menadiol diphosphate (vitamin K3) in advanced malignancy | 2005 | 42 | Neuroendocrine Tumor Research Advances |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular formula and weight of Menadiol sodium diphosphate?
Which companies hold the most patents related to Menadiol sodium diphosphate?
What are common alternative names for this compound?
What are the primary patent application areas for Menadiol sodium diphosphate?
What research topics have been published about Menadiol sodium diphosphate?